Annex to agenda of the CHMP meeting 10-13 November 2025
Submitted by Anonymous (not verified) on 10 November 2025 - 13:42
Annex to agenda of the CHMP meeting 10-13 November 2025
Agenda of the CHMP meeting 10-13 November 2025
Submitted by Anonymous (not verified) on 10 November 2025 - 13:40
Agenda of the CHMP meeting 10-13 November 2025
Pharmacovigilance-related regulatory recommendations for centrally authorised veterinary medicinal products during 2025
Submitted by Anonymous (not verified) on 10 November 2025 - 8:52
Pharmacovigilance-related regulatory recommendations for centrally authorised veterinary medicinal products during 2025
Human medicines European public assessment report (EPAR): HBVaxPro, hepatitis B vaccine (recombinant DNA), Date of authorisation: 27/04/2001, Revision: 35, Status: Authorised
Submitted by Anonymous (not verified) on 7 November 2025 - 15:00
Human medicines European public assessment report (EPAR): HBVaxPro, hepatitis B vaccine (recombinant DNA), Date of authorisation: 27/04/2001, Revision: 35, Status: Authorised
MSSG Voluntary Solidarity Mechanism
Submitted by Anonymous (not verified) on 7 November 2025 - 14:54
MSSG Voluntary Solidarity Mechanism
Clinical Trial Information System (CTIS) structured data form - Initial application, additional Member State Concerned, (Multi trial) substantial modification, non-substantial modification, and Request for information (RFI)
Submitted by Anonymous (not verified) on 7 November 2025 - 14:51
Clinical Trial Information System (CTIS) structured data form - Initial application, additional Member State Concerned, (Multi trial) substantial modification, non-substantial modification, and Request for information (RFI)
Orphan designation: obinutuzumab Treatment of follicular lymphoma, 19/06/2015 Withdrawn
Submitted by Anonymous (not verified) on 7 November 2025 - 14:19
Orphan designation: obinutuzumab Treatment of follicular lymphoma, 19/06/2015 Withdrawn
Meeting highlights from the Committee for Veterinary Medicinal Products (CVMP) 4-6 November 2025
Submitted by Anonymous (not verified) on 7 November 2025 - 14:00
Meeting highlights from the Committee for Veterinary Medicinal Products (CVMP) 4-6 November 2025
Summary of opinion: Frontpro (previously Afoxolaner Merial) Positive
Submitted by Anonymous (not verified) on 7 November 2025 - 14:00
Summary of opinion: Frontpro (previously Afoxolaner Merial) Positive
Summary of opinion: Mhyosphere PCV ID, 06/11/2025 Positive
Submitted by Anonymous (not verified) on 7 November 2025 - 14:00
Summary of opinion: Mhyosphere PCV ID, 06/11/2025 Positive